1 ~ INSTRUCTIONS: Please answer the following five questions to inform the community about yourself and enhance your experience at the Ashland Source Center. Answers are NOT REQUIRED to join, and you can always fill them out later on your MYPORTAL page.
2 ~ What brought you to Ashland & Southern Oregon area? Let us know what’s been inspiring you these days!
My husband and I were looking for a new place to live so we took a tour of the west coast on our honeymoon. We stopped in Ashland to see a play and visit the area and promptly bought 38 acres of property out in the Applegate Valley. That was in 1988.
3 ~ What would you love to offer to and share with our community? What do you envision could be a few of the most beneficial things that could happen from actively using this site? Feel free to be outrageous!
Energy medicine classes and treatment sessions, as well as therapeutic massage.
Bio Mat Distributor.
4 ~ Please describe any projects or businesses you'd like to develop, if any? What is your "JOB" (aka "Joy of Being")? What especially delights you?
Along with Debra Hurt Burchard, I will be teaching the first year of Donna Eden's two-year Energy Medicine Certification Program here in the Rogue Valley as well as in the Bay Area. Some day I'd like to co-create a full energy medicine program within a massage school that would run alongside the massage and science curriculums. I imagine this to be a 1000 hour, 15 month program much like the Boulder College of Massage Therapy in Boulder, Colorado.
5 ~ Which intriguing concepts, local endeavors, links, music, art, websites, books, films, inventions have you been exploring?
I frequently recommend the Abraham-Hicks books and CDs, as well as James Ray's books and videos. The book that has had the biggest impact in my life recently is The Way of Mastery - along the lines of A Course in Miracles, but infinitely more readable.
Janie's Top Five Movies: Songcatcher, Monsoon Wedding, Bagdad Cafe, African Queen, Phenomenon.
My family LOVES rockin' to Michael Franti!
May your creative projects all be blessed. You can utilize this network as it grows to promote yourself and your projects/business/organizations. This is our own community version of MySpace/FaceBook.
You can fill out your "MyPage" with more information and resources. In the "text" box you can add a description, photos, etc. In the "RSS" box you can add any RSS feed. You can also upload a profile photo under "MySettings" so we can feature your page.
Use this network to promote yourself in the local community by inviting your friends under "Members" to see your "MyPage" profile and add their own. This is how the network grows strong and we are kept informed locally.
Drawing on statements of numerous scholars from around the world—virologists, epidemiologists, immunologists, pathologists, microbiologists, infectious disease specialists, including Nobel Prize winners, as well as front-line ER physicians and family practice MDs—veteran journalist James Perloff asks hard questions about the global response to COVID-19.
Lockdowns and hygienic measures around the world are based on numbers of cases and mortality rates created by the so-called SARS-CoV-2 RT-PCR tests used to identify “positive” patients, whereby “positive” is usually equated with “infected.”
But looking closely at the facts, the conclusion is that these PCR tests are meaningless as a diagnostic tool to determine an alleged infection by a supposedly new virus called SARS-CoV-2.
The World Health Organization (WHO) has defended its study on Remdesivir after its developer argued that the results were "inconsistent" with previous studies. The WHO trial claimed that the drug doesn't help Covid-19 patients.
“It's a reliable result, don't let anybody tell you otherwise, because they'll try to,” Richard Peto, an independent statistician hired by the WHO to evaluate its trial, told reporters on Friday. He argued that any benefits from Remdesivir may be due to chance, according to Reuters.
The WHO-funded study of four antiviral drugs, including Remdesivir and Hydroxychloroquine, involved more than 11,000 Covid-19 patients in 30 countries. It found that all of the drugs tested had “little or no effect” on mortality, the need to be ventilated or the amount of days spent in a hospital.
Remdesivir's developer Gilead Sciences noted that the results of the trial have not been peer-reviewed and argued that they “appear inconsistent with more robust evidence from multiple randomized, controlled studies published in peer-reviewed journals.” The California-based company said that the benefits from Remdesivir for Covid-19 patients were demonstrated in three previous trials, the results of which were published in the New England Journal of Medicine last week.
A Centers for Disease Control report released in September shows that masks and face coverings are not effective in preventing the spread of COVID-19, even for those people who consistently wear them.
A study conducted in the United States in July found that when they compared 154 “case-patients,” who tested positive for COVID-19, to a control group of 160 participants from the same health care facility who were symptomatic but tested negative, over 70 percent of the case-patients were contaminated with the virus and fell ill despite “always” wearing a mask.
“In the 14 days before illness onset, 71% of case-patients and 74% of control participants reported always using cloth face coverings or other mask types when in public,” the report stated.